ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Swine Vaccines Market Research Report 2026
Published Date: 2026-01-15
|
Report Code: QYRE-Auto-6J9176
Home | Market Reports
Global Swine Vaccines Market Outlook 2022
BUY CHAPTERS

Global Swine Vaccines Market Research Report 2026

Code: QYRE-Auto-6J9176
Report
2026-01-15
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis Inc
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Cavet Bio
BIGVET Biotech

Swine Vaccines Market Size

The global Swine Vaccines market was valued at US$ 1604 million in 2025 and is anticipated to reach US$ 2103 million by 2032, at a CAGR of 4.0% from 2026 to 2032.

Swine Vaccines Market

Swine Vaccines Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Swine Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Swine vaccines are biological preparations designed to prevent and control infectious diseases in pigs by stimulating specific antibody and cellular immune responses. They are classified into inactivated, live attenuated, subunit, recombinant, and nucleic acid vaccines, widely applied against key swine diseases such as classical swine fever, PRRS, pseudorabies, foot-and-mouth disease, porcine circovirus, and mycoplasmal pneumonia. As modern pig farming shifts toward intensive and high-efficiency operations, swine vaccines have become essential tools for improving herd health, enhancing productivity, ensuring food safety, and safeguarding public health. The industry’s innovation trend is evolving from traditional prophylaxis to precision immunization and multivalent combination vaccine technologies. In 2024, global Swine vaccines production reached approximately 12.56 billion units , with an average global market price of around US$ 123 k unit.The average gross profit margin for this product is 70%.
The global swine vaccine market is experiencing structural growth opportunities. The ongoing threat of highly pathogenic diseases such as African swine fever and PRRS has prompted governments to strengthen animal health infrastructure, while companies increasingly prioritize preventive immunization over therapeutic solutions. Meanwhile, advances in biotechnology and genetic engineering are accelerating the commercialization of next-generation vaccines—including DNA, mRNA, and adjuvant-optimized formulations—creating new growth engines for global animal health leaders. In regions such as China, Southeast Asia, and Latin America, rapid consolidation of pig farming is boosting demand for high-safety, broad-spectrum vaccines, marking a new phase of technology-driven and brand-oriented competition.
Despite its strong outlook, the industry faces multiple risks including regulatory complexity, technological barriers, and market volatility. Stricter vaccine approval procedures—especially for recombinant and genetic vaccines—extend product launch timelines and increase R&D costs, limiting smaller firms’ participation. In addition, fluctuating raw material prices, cold-chain logistics requirements, and unpredictable outbreaks create operational uncertainty. The circulation of unlicensed vaccines and inconsistent immunization practices in certain regions further undermine market integrity and trust.
Demand from pig producers is shifting from “disease prevention” toward “integrated herd health management.” Large-scale farms and agri-food conglomerates are adopting comprehensive immunization solutions, accelerating the adoption of multivalent and precision vaccination systems. Growing consumer concerns over pork safety and traceability are reinforcing the need for regulated vaccination programs. Future market evolution will emphasize the integration of immunization monitoring, digital farming, and biosecurity management, fostering a value-driven, data-linked vaccine ecosystem.
The upstream supply chain of swine vaccines includes antigens, culture media, adjuvants, stabilizers, and packaging materials. Optimizing antigen production and virus culture systems remains key to cost control and batch consistency. Some premium vaccine components—such as advanced cell media and imported adjuvants—still rely on international suppliers, posing supply chain risks. However, with advances in domestic fermentation, synthetic biology, and formulation technologies, local substitution is accelerating. High-purity materials and customized bioreactor systems are expected to become crucial differentiators for vaccine manufacturers.
This report delivers a comprehensive overview of the global Swine Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Swine Vaccines. The Swine Vaccines market size, estimates, and forecasts are provided in terms of sales volume (M Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Swine Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Swine Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Swine Vaccines Market Report

Report Metric Details
Report Name Swine Vaccines Market
Accounted market size in 2025 US$ 1604 million
Forecasted market size in 2032 US$ 2103 million
CAGR 4.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • CSF Vaccines
  • FMD Vaccines
  • Porcine Circovirus Vaccines
  • PRRS Vaccines
  • Others
by Application
  • Government Tender
  • Market Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, Hipra, Ringpu Biology, ChengDu Tecbond, DHN, CAVAC, Virbac, HVRI, Bioveta, Cavet Bio, BIGVET Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Swine Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Swine Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Swine Vaccines Market growing?

Ans: The Swine Vaccines Market witnessing a CAGR of 4.0% during the forecast period 2026-2032.

What is the Swine Vaccines Market size in 2032?

Ans: The Swine Vaccines Market size in 2032 will be US$ 2103 million.

Who are the main players in the Swine Vaccines Market report?

Ans: The main players in the Swine Vaccines Market are Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, Hipra, Ringpu Biology, ChengDu Tecbond, DHN, CAVAC, Virbac, HVRI, Bioveta, Cavet Bio, BIGVET Biotech

What are the Application segmentation covered in the Swine Vaccines Market report?

Ans: The Applications covered in the Swine Vaccines Market report are Government Tender, Market Sales

What are the Type segmentation covered in the Swine Vaccines Market report?

Ans: The Types covered in the Swine Vaccines Market report are CSF Vaccines, FMD Vaccines, Porcine Circovirus Vaccines, PRRS Vaccines, Others

1 Swine Vaccines Market Overview
1.1 Product Definition
1.2 Swine Vaccines by Type
1.2.1 Global Swine Vaccines Market Value by Type: 2025 vs 2032
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Others
1.3 Swine Vaccines by Application
1.3.1 Global Swine Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Swine Vaccines Market Size Estimates and Forecasts
1.4.1 Global Swine Vaccines Revenue 2021–2032
1.4.2 Global Swine Vaccines Sales 2021–2032
1.4.3 Global Swine Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Swine Vaccines Market Competition by Manufacturers
2.1 Global Swine Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Swine Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Swine Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Swine Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Swine Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Swine Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Swine Vaccines, Date of Entry into the Industry
2.8 Global Swine Vaccines Market Competitive Situation and Trends
2.8.1 Global Swine Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Swine Vaccines Players Market Share by Revenue
2.8.3 Global Swine Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Swine Vaccines Market Scenario by Region
3.1 Global Swine Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Swine Vaccines Sales by Region: 2021–2032
3.2.1 Global Swine Vaccines Sales by Region: 2021–2026
3.2.2 Global Swine Vaccines Sales by Region: 2027–2032
3.3 Global Swine Vaccines Revenue by Region: 2021–2032
3.3.1 Global Swine Vaccines Revenue by Region: 2021–2026
3.3.2 Global Swine Vaccines Revenue by Region: 2027–2032
3.4 North America Swine Vaccines Market Facts & Figures by Country
3.4.1 North America Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Swine Vaccines Sales by Country (2021–2032)
3.4.3 North America Swine Vaccines Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Swine Vaccines Market Facts & Figures by Country
3.5.1 Europe Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Swine Vaccines Sales by Country (2021–2032)
3.5.3 Europe Swine Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Swine Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Swine Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Swine Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Swine Vaccines Market Facts & Figures by Country
3.7.1 Latin America Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Swine Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Swine Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Swine Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Swine Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Swine Vaccines Sales by Type (2021–2032)
4.1.1 Global Swine Vaccines Sales by Type (2021–2026)
4.1.2 Global Swine Vaccines Sales by Type (2027–2032)
4.1.3 Global Swine Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Swine Vaccines Revenue by Type (2021–2032)
4.2.1 Global Swine Vaccines Revenue by Type (2021–2026)
4.2.2 Global Swine Vaccines Revenue by Type (2027–2032)
4.2.3 Global Swine Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Swine Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Swine Vaccines Sales by Application (2021–2032)
5.1.1 Global Swine Vaccines Sales by Application (2021–2026)
5.1.2 Global Swine Vaccines Sales by Application (2027–2032)
5.1.3 Global Swine Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Swine Vaccines Revenue by Application (2021–2032)
5.2.1 Global Swine Vaccines Revenue by Application (2021–2026)
5.2.2 Global Swine Vaccines Revenue by Application (2027–2032)
5.2.3 Global Swine Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Swine Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Swine Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Jinyu Bio-Technology
6.3.1 Jinyu Bio-Technology Company Information
6.3.2 Jinyu Bio-Technology Description and Business Overview
6.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
6.3.5 Jinyu Bio-Technology Recent Developments/Updates
6.4 CAHIC
6.4.1 CAHIC Company Information
6.4.2 CAHIC Description and Business Overview
6.4.3 CAHIC Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 CAHIC Swine Vaccines Product Portfolio
6.4.5 CAHIC Recent Developments/Updates
6.5 Tecon
6.5.1 Tecon Company Information
6.5.2 Tecon Description and Business Overview
6.5.3 Tecon Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Tecon Swine Vaccines Product Portfolio
6.5.5 Tecon Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Company Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Zoetis Swine Vaccines Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Ceva
6.7.1 Ceva Company Information
6.7.2 Ceva Description and Business Overview
6.7.3 Ceva Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ceva Swine Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Hile Bio
6.8.1 Hile Bio Company Information
6.8.2 Hile Bio Description and Business Overview
6.8.3 Hile Bio Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hile Bio Swine Vaccines Product Portfolio
6.8.5 Hile Bio Recent Developments/Updates
6.9 Chopper Biology
6.9.1 Chopper Biology Company Information
6.9.2 Chopper Biology Description and Business Overview
6.9.3 Chopper Biology Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Chopper Biology Swine Vaccines Product Portfolio
6.9.5 Chopper Biology Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Company Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 WINSUN Swine Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Hipra
6.11.1 Hipra Company Information
6.11.2 Hipra Description and Business Overview
6.11.3 Hipra Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hipra Swine Vaccines Product Portfolio
6.11.5 Hipra Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Company Information
6.12.2 Ringpu Biology Description and Business Overview
6.12.3 Ringpu Biology Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Ringpu Biology Swine Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 ChengDu Tecbond
6.13.1 ChengDu Tecbond Company Information
6.13.2 ChengDu Tecbond Description and Business Overview
6.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
6.13.5 ChengDu Tecbond Recent Developments/Updates
6.14 DHN
6.14.1 DHN Company Information
6.14.2 DHN Description and Business Overview
6.14.3 DHN Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 DHN Swine Vaccines Product Portfolio
6.14.5 DHN Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Company Information
6.15.2 CAVAC Description and Business Overview
6.15.3 CAVAC Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 CAVAC Swine Vaccines Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 Virbac
6.16.1 Virbac Company Information
6.16.2 Virbac Description and Business Overview
6.16.3 Virbac Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Virbac Swine Vaccines Product Portfolio
6.16.5 Virbac Recent Developments/Updates
6.17 HVRI
6.17.1 HVRI Company Information
6.17.2 HVRI Description and Business Overview
6.17.3 HVRI Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 HVRI Swine Vaccines Product Portfolio
6.17.5 HVRI Recent Developments/Updates
6.18 Bioveta
6.18.1 Bioveta Company Information
6.18.2 Bioveta Description and Business Overview
6.18.3 Bioveta Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Bioveta Swine Vaccines Product Portfolio
6.18.5 Bioveta Recent Developments/Updates
6.19 Cavet Bio
6.19.1 Cavet Bio Company Information
6.19.2 Cavet Bio Description and Business Overview
6.19.3 Cavet Bio Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Cavet Bio Swine Vaccines Product Portfolio
6.19.5 Cavet Bio Recent Developments/Updates
6.20 BIGVET Biotech
6.20.1 BIGVET Biotech Company Information
6.20.2 BIGVET Biotech Description and Business Overview
6.20.3 BIGVET Biotech Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 BIGVET Biotech Swine Vaccines Product Portfolio
6.20.5 BIGVET Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Vaccines Industry Chain Analysis
7.2 Swine Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Vaccines Production Mode & Process Analysis
7.4 Swine Vaccines Sales and Marketing
7.4.1 Swine Vaccines Sales Channels
7.4.2 Swine Vaccines Distributors
7.5 Swine Vaccines Customer Analysis
8 Swine Vaccines Market Dynamics
8.1 Swine Vaccines Industry Trends
8.2 Swine Vaccines Market Drivers
8.3 Swine Vaccines Market Challenges
8.4 Swine Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis Inc
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Cavet Bio
BIGVET Biotech
List of Tables
 Table 1. Global Swine Vaccines Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Swine Vaccines Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Swine Vaccines Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Swine Vaccines Sales (M Doses) of Key Manufacturers (2021–2026)
 Table 5. Global Swine Vaccines Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Swine Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Swine Vaccines Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Swine Vaccines Average Price (USD/K Doses) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Swine Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Swine Vaccines, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Swine Vaccines, Product Types and Applications
 Table 12. Global Key Manufacturers of Swine Vaccines, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Swine Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Swine Vaccines Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Swine Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Swine Vaccines Sales by Region (M Doses), 2021–2026
 Table 18. Global Swine Vaccines Sales Market Share by Region (2021–2026)
 Table 19. Global Swine Vaccines Sales by Region (M Doses), 2027–2032
 Table 20. Global Swine Vaccines Sales Market Share by Region (2027–2032)
 Table 21. Global Swine Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Swine Vaccines Revenue Market Share by Region (2021–2026)
 Table 23. Global Swine Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Swine Vaccines Revenue Market Share by Region (2027–2032)
 Table 25. North America Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Swine Vaccines Sales by Country (M Doses), 2021–2026
 Table 27. North America Swine Vaccines Sales by Country (M Doses), 2027–2032
 Table 28. North America Swine Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Swine Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Swine Vaccines Sales by Country (M Doses), 2021–2026
 Table 32. Europe Swine Vaccines Sales by Country (M Doses), 2027–2032
 Table 33. Europe Swine Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Swine Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Swine Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Swine Vaccines Sales by Region (M Doses), 2021–2026
 Table 37. Asia Pacific Swine Vaccines Sales by Region (M Doses), 2027–2032
 Table 38. Asia Pacific Swine Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Swine Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Swine Vaccines Sales by Country (M Doses), 2021–2026
 Table 42. Latin America Swine Vaccines Sales by Country (M Doses), 2027–2032
 Table 43. Latin America Swine Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Swine Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Swine Vaccines Sales by Country (M Doses), 2021–2026
 Table 47. Middle East and Africa Swine Vaccines Sales by Country (M Doses), 2027–2032
 Table 48. Middle East and Africa Swine Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Swine Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Swine Vaccines Sales (M Doses) by Type (2021–2026)
 Table 51. Global Swine Vaccines Sales (M Doses) by Type (2027–2032)
 Table 52. Global Swine Vaccines Sales Market Share by Type (2021–2026)
 Table 53. Global Swine Vaccines Sales Market Share by Type (2027–2032)
 Table 54. Global Swine Vaccines Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Swine Vaccines Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Swine Vaccines Revenue Market Share by Type (2021–2026)
 Table 57. Global Swine Vaccines Revenue Market Share by Type (2027–2032)
 Table 58. Global Swine Vaccines Price (USD/K Doses) by Type (2021–2026)
 Table 59. Global Swine Vaccines Price (USD/K Doses) by Type (2027–2032)
 Table 60. Global Swine Vaccines Sales (M Doses) by Application (2021–2026)
 Table 61. Global Swine Vaccines Sales (M Doses) by Application (2027–2032)
 Table 62. Global Swine Vaccines Sales Market Share by Application (2021–2026)
 Table 63. Global Swine Vaccines Sales Market Share by Application (2027–2032)
 Table 64. Global Swine Vaccines Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Swine Vaccines Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Swine Vaccines Revenue Market Share by Application (2021–2026)
 Table 67. Global Swine Vaccines Revenue Market Share by Application (2027–2032)
 Table 68. Global Swine Vaccines Price (USD/K Doses) by Application (2021–2026)
 Table 69. Global Swine Vaccines Price (USD/K Doses) by Application (2027–2032)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 73. Merck Swine Vaccines Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Boehringer Ingelheim Company Information
 Table 76. Boehringer Ingelheim Description and Business Overview
 Table 77. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 78. Boehringer Ingelheim Swine Vaccines Product
 Table 79. Boehringer Ingelheim Recent Developments/Updates
 Table 80. Jinyu Bio-Technology Company Information
 Table 81. Jinyu Bio-Technology Description and Business Overview
 Table 82. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 83. Jinyu Bio-Technology Swine Vaccines Product
 Table 84. Jinyu Bio-Technology Recent Developments/Updates
 Table 85. CAHIC Company Information
 Table 86. CAHIC Description and Business Overview
 Table 87. CAHIC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 88. CAHIC Swine Vaccines Product
 Table 89. CAHIC Recent Developments/Updates
 Table 90. Tecon Company Information
 Table 91. Tecon Description and Business Overview
 Table 92. Tecon Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 93. Tecon Swine Vaccines Product
 Table 94. Tecon Recent Developments/Updates
 Table 95. Zoetis Company Information
 Table 96. Zoetis Description and Business Overview
 Table 97. Zoetis Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 98. Zoetis Swine Vaccines Product
 Table 99. Zoetis Recent Developments/Updates
 Table 100. Ceva Company Information
 Table 101. Ceva Description and Business Overview
 Table 102. Ceva Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 103. Ceva Swine Vaccines Product
 Table 104. Ceva Recent Developments/Updates
 Table 105. Hile Bio Company Information
 Table 106. Hile Bio Description and Business Overview
 Table 107. Hile Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 108. Hile Bio Swine Vaccines Product
 Table 109. Hile Bio Recent Developments/Updates
 Table 110. Chopper Biology Company Information
 Table 111. Chopper Biology Description and Business Overview
 Table 112. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 113. Chopper Biology Swine Vaccines Product
 Table 114. Chopper Biology Recent Developments/Updates
 Table 115. WINSUN Company Information
 Table 116. WINSUN Description and Business Overview
 Table 117. WINSUN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 118. WINSUN Swine Vaccines Product
 Table 119. WINSUN Recent Developments/Updates
 Table 120. Hipra Company Information
 Table 121. Hipra Description and Business Overview
 Table 122. Hipra Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 123. Hipra Swine Vaccines Product
 Table 124. Hipra Recent Developments/Updates
 Table 125. Ringpu Biology Company Information
 Table 126. Ringpu Biology Description and Business Overview
 Table 127. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 128. Ringpu Biology Swine Vaccines Product
 Table 129. Ringpu Biology Recent Developments/Updates
 Table 130. ChengDu Tecbond Company Information
 Table 131. ChengDu Tecbond Description and Business Overview
 Table 132. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 133. ChengDu Tecbond Swine Vaccines Product
 Table 134. ChengDu Tecbond Recent Developments/Updates
 Table 135. DHN Company Information
 Table 136. DHN Description and Business Overview
 Table 137. DHN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 138. DHN Swine Vaccines Product
 Table 139. DHN Recent Developments/Updates
 Table 140. CAVAC Company Information
 Table 141. CAVAC Description and Business Overview
 Table 142. CAVAC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 143. CAVAC Swine Vaccines Product
 Table 144. CAVAC Recent Developments/Updates
 Table 145. Virbac Company Information
 Table 146. Virbac Description and Business Overview
 Table 147. Virbac Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 148. Virbac Swine Vaccines Product
 Table 149. Virbac Recent Developments/Updates
 Table 150. HVRI Company Information
 Table 151. HVRI Description and Business Overview
 Table 152. HVRI Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 153. HVRI Swine Vaccines Product
 Table 154. HVRI Recent Developments/Updates
 Table 155. Bioveta Company Information
 Table 156. Bioveta Description and Business Overview
 Table 157. Bioveta Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 158. Bioveta Swine Vaccines Product
 Table 159. Bioveta Recent Developments/Updates
 Table 160. Cavet Bio Company Information
 Table 161. Cavet Bio Description and Business Overview
 Table 162. Cavet Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 163. Cavet Bio Swine Vaccines Product
 Table 164. Cavet Bio Recent Developments/Updates
 Table 165. BIGVET Biotech Company Information
 Table 166. BIGVET Biotech Description and Business Overview
 Table 167. BIGVET Biotech Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 168. BIGVET Biotech Swine Vaccines Product
 Table 169. BIGVET Biotech Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Swine Vaccines Distributors List
 Table 173. Swine Vaccines Customers List
 Table 174. Swine Vaccines Market Trends
 Table 175. Swine Vaccines Market Drivers
 Table 176. Swine Vaccines Market Challenges
 Table 177. Swine Vaccines Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Swine Vaccines
 Figure 2. Global Swine Vaccines Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Swine Vaccines Market Share by Type: 2025 & 2032
 Figure 4. CSF Vaccines Product Picture
 Figure 5. FMD Vaccines Product Picture
 Figure 6. Porcine Circovirus Vaccines Product Picture
 Figure 7. PRRS Vaccines Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Swine Vaccines Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global Swine Vaccines Market Share by Application: 2025 & 2032
 Figure 11. Government Tender
 Figure 12. Market Sales
 Figure 13. Global Swine Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Swine Vaccines Market Size (US$ Million), 2021–2032
 Figure 15. Global Swine Vaccines Sales (M Doses), 2021–2032
 Figure 16. Global Swine Vaccines Average Price (USD/K Doses), 2021–2032
 Figure 17. Swine Vaccines Report Years Considered
 Figure 18. Swine Vaccines Sales Share by Manufacturers in 2025
 Figure 19. Global Swine Vaccines Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Swine Vaccines Players: Market Share by Revenue in Swine Vaccines in 2025
 Figure 21. Swine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Swine Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Swine Vaccines Sales Market Share by Country (2021–2032)
 Figure 24. North America Swine Vaccines Revenue Market Share by Country (2021–2032)
 Figure 25. U.S. Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Swine Vaccines Sales Market Share by Country (2021–2032)
 Figure 28. Europe Swine Vaccines Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Swine Vaccines Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Swine Vaccines Revenue Market Share by Region (2021–2032)
 Figure 36. China Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Taiwan Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Indonesia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Thailand Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Malaysia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Philippines Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Swine Vaccines Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Swine Vaccines Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Swine Vaccines Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Swine Vaccines Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. U.A.E Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Swine Vaccines by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Swine Vaccines by Type (2021–2032)
 Figure 58. Global Swine Vaccines Price (USD/K Doses) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Swine Vaccines by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Swine Vaccines by Application (2021–2032)
 Figure 61. Global Swine Vaccines Price (USD/K Doses) by Application (2021–2032)
 Figure 62. Swine Vaccines Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Livestock Animal Vaccines Market Research Report 2024
Global Livestock Animal Vaccination Market Research Report 2025
Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Vaccine Market
Global Veterinary Vaccination Market Research Report 2025
Global Veterinary Biological Vaccines Market Research Report 2025
Global Livestock Vaccines Market Research Report 2025
Global Travelers Vaccines Market Research Report 2025
Global Travelers Vaccination Market Research Report 2025
Global Human Vaccination Market Research Report 2025
Global Dog Vaccines Market Insights Forecast to 2030
Ruminant Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Vaccine Include COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Porcine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Livestock Vaccines and Poultry Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bacterial Vaccines for Humans Market Research Report 2024
Swine Streptococcus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Vaccines Market Insights Forecast to 2030
Global Livestock mRNA Vaccines Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions